Majin Castillo

Majin Castillo

Company: Reistone Biopharma

Job title: Sr Medical Director


A Highly Selective JAK inhibitor SHR0302 for the Treatment of Patients with Moderate to Severe Atopic Dermatitis: A Successful Phase II Study 12:00 pm

• Showcasing phase II study results • Learnings from conducting dermatological trial in China • Sharing experience on conducting big indication clinical study for a startup biotechRead more

day: Day 2 AM - Track 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.